World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
90
Citations
35628
World Ranking
12079
National Ranking
354

Overview

Namiki Izumi is affiliated with Musashino Red Cross Hospital in Japan and specializes in medical research with a strong focus on hepatology. Their work spans multiple subfields including hepatology, epidemiology, oncology, cancer research, and surgery, contributing extensively to the field of medicine.

The scientist's research covers a variety of topics primarily related to liver disease and cancer. These main topics include:

  • Liver Disease Diagnosis and Treatment
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Hepatitis C Virus Research
  • Hepatitis B Virus Studies
  • Liver Disease and Transplantation
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Cancer, Lipids, and Metabolism

Namiki Izumi has contributed to numerous research articles published in prominent journals. Notable recent papers include:

  • Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update, 2021, Liver Cancer
  • Surgery versus Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Randomized Controlled Trial (SURF Trial), 2021, Liver Cancer
  • Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis, 2023, The Lancet. Gastroenterology & Hepatology
  • Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma, 2022, Liver Cancer
  • Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants, 2022, Gastroenterology

Their research has appeared frequently in specific publication venues such as:

  • Hepatology Research
  • Alimentary Pharmacology & Therapeutics
  • JGH Open
  • Journal of Clinical Oncology
  • Journal of Hepatology

Namiki Izumi has collaborated extensively with several co-authors over their career. Frequent co-authors include:

  • Masayuki Kurosaki
  • Nobuharu Tamaki
  • Yutaka Yasui
  • Kaoru Tsuchiya
  • Hiroyuki Nakanishi

Best Publications

  • Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.

    Yasuhito Tanaka;Nao Nishida;Masaya Sugiyama;Masayuki Kurosaki

  • Mutations in the Nonstructural Protein 5a Gene and Response to Interferon in Patients with Chronic Hepatitis C Virus 1b Infection

    Nobuyuki Enomoto;Ikuo Sakuma;Yasuhiro Asahina;Masayuki Kurosaki

  • Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version

    Masatoshi Kudo;Namiki Izumi;Norihiro Kokudo;Osamu Matsui

  • Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region.

    N Enomoto;I Sakuma;Y Asahina;M Kurosaki

  • Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection.

    Hiromitsu Kumada;Yoshiyuki Suzuki;Kenji Ikeda;Joji Toyota

  • JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan

    Masatoshi Kudo;Osamu Matsui;Namiki Izumi;Hiroko Iijima

  • Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial.

    Masatoshi Kudo;Kazuomi Ueshima;Masafumi Ikeda;Takuji Torimura

  • Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

    Maria Buti;Edward Gane;Wai Kay Seto;Henry L.Y. Chan

  • Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion

    Takashi Kokudo;Kiyoshi Hasegawa;Yutaka Matsuyama;Tadatoshi Takayama

  • Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines)

    Norihiro Kokudo;Kiyoshi Hasegawa;Masaaki Akahane;Hiroshi Igaki

  • Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial.

    Masashi Mizokami;Osamu Yokosuka;Tetsuo Takehara;Naoya Sakamoto

  • Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH-HCC guidelines) 2019 update.

    Norihiro Kokudo;Nobuyuki Takemura;Kiyoshi Hasegawa;Tadatoshi Takayama

  • Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update.

    Masatoshi Kudo;Yusuke Kawamura;Kiyoshi Hasegawa;Ryosuke Tateishi

  • Comparison of resection and ablation for hepatocellular carcinoma: A cohort study based on a Japanese nationwide survey

    Kiyoshi Hasegawa;Norihiro Kokudo;Masatoshi Makuuchi;Namiki Izumi

  • Branched-chain amino acids as pharmacological nutrients in chronic liver disease.

    Takumi Kawaguchi;Namiki Izumi;Michael R. Charlton;Michio Sata

  • 96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection

    Kosh Agarwal;Maurizia Brunetto;Wai Kay Seto;Young-Suk Lim

  • Influence of Hepatitis B Virus Genotypes on the Intra- and Extracellular Expression of Viral DNA and Antigens

    Masaya Sugiyama;Yasuhito Tanaka;Takanobu Kato;Etsuro Orito

  • Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection

    Yasuhiro Asahina;Kaoru Tsuchiya;Nobuharu Tamaki;Itsuko Hirayama

  • Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial.

    Masatoshi Kudo;Kazuomi Ueshima;Osamu Yokosuka;Sadahisa Ogasawara

  • RAPID COMMUNICATION Daclatasvir Plus Asunaprevir for Chronic HCV Genotype 1b Infection

    Hiromitsu Kumada;Yoshiyuki Suzuki;Kenji Ikeda;Joji Toyota

Frequent Co-Authors

Yutaka Yasui
Yutaka Yasui St. Jude Children's Research Hospital
Nobuyuki Enomoto
Nobuyuki Enomoto University of Yamanashi
Hiroyuki Nakanishi
Hiroyuki Nakanishi Kumamoto University
Masatoshi Kudo
Masatoshi Kudo Kindai University
Norihiro Kokudo
Norihiro Kokudo National Center For Global Health and Medicine
Michiie Sakamoto
Michiie Sakamoto Keio University
Yasuhito Tanaka
Yasuhito Tanaka Kumamoto University
Masashi Mizokami
Masashi Mizokami National Center For Global Health and Medicine
Hiromitsu Kumada
Hiromitsu Kumada Fukuoka University
Shuichi Kaneko
Shuichi Kaneko Kanazawa University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring the world of medicine doesn’t just mean attending medical school in person. Many students now start or advance their healthcare careers with flexible and affordable online degree options. These programs allow you to study on your schedule, often while keeping your current job.

For those interested in advanced practice, there are several online nurse practitioner programs that prepare registered nurses for leadership and specialized clinical roles. If you are just starting, consider earning your degree through a reputable nursing school online. These programs can help you begin your career as a nurse or move forward as a registered nurse.

Ambitious nurses may enhance their credentials and impact the healthcare field by enrolling in online phd programs in nursing, paving the way for careers in research, teaching, or upper management. Those seeking a more budget-friendly path to advance from RN to BSN can review the cheapest bsn programs online.

No matter your starting point, these online options create more accessible pathways for aspiring healthcare professionals in the USA.

Best Scientists Citing Namiki Izumi

Trending Scientists

Recently Published Articles